Revive Therapeutics (RVV.V) is a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders. The company offers cannabinoid pharmaceutical portfolio that focuses on rare inflammatory diseases. It is developing Bucillamine, which is in Phase 3 clinical study for the treatment of infectious diseases, including influenza and COVID-19. Today, Revive Therapeutics provided an update on the Company’s clinical study evaluating the safety and feasibility of oral psilocybin as a potential treatment for methamphetamine use disorder co ..read more

Lophos Pharmaceuticals Corp. (MESC.C), a key player in the Canadian biosciences/psychedelics sector, has made a significant leap forward in the field of psychoactive compound research and development as it has announced the successful finalization of a new synthetic mescaline production protocol, marking a major milestone in the accessibility and study of psychoactive substances. This development represents a culmination of rigorous research and innovation, aimed at enhancing the production processes of synthetic mescaline, ensuring consistency, purity, and adherence to the highest industry st ..read more

What a time to be alive; there was a period in our civilized history where getting alcohol on a Sunday was a tough racket, now we’re exploring the safe supply of cocaine, goverment sold weed, prescribed MDMA, magic mushroom microdosing and, increasingly, the wondrous powers of peyote being safely available to those who partake. It hasn’t always been easy to do the peyote thing, at least without befriending a self-professed ‘shaman’, usually a first year BCIT Engineering student with dreadlocks who calls himself Mujambo (though his student ID says Charles) and crashing a Third Beach drum circle ..read more

What a time to be alive; there was a period in our civilized history where getting alcohol on a Sunday was a tough racket, now we’re exploring the safe supply of cocaine, goverment sold weed, prescribed MDMA, magic mushroom microdosing and, increasingly, the wondrous powers of peyote being safely available to those who partake. It hasn’t always been easy to do the peyote thing, at least without befriending a self-professed ‘shaman’, usually a first year BCIT Engineering student with dreadlocks who calls himself Mujambo (though his student ID says Charles) and crashing a Third Beach drum circle ..read more

In Canada, the prevalence of depression and mental health disorders has shown a worrying increase. According to data from 2022, over 5 million Canadians, accounting for 18% of the population aged 15 and older. This growing trend underscores the importance of addressing mental health issues at a societal and policy level, with an emphasis on creating accessible and effective mental health care systems. Traditional treatments, such as selective serotonin reuptake inhibitors (SSRIs), often have limited efficacy, and a notable proportion of patients do not respond adequately to them. Companies lik ..read more

Several years back, Hugh Rogers was in my office talking about his cannabis company. Way back then, the plan was to grow in Germany and be first on the continent, using an old wartime bunker as a ‘safe growing facility’. Those plans morphed quickly as the reality of the cannabis space became clear. The cannabis market did what it did, and weed wasn’t all it was cracked up to be… this is no secret. But while some ran their weed deals into walls and off cliffs like Wile E. Coyote, insisting any day now the good time would start to roll… Rogers tacked left. EVOLUTION BEATS REVOLUTION Rogers didn ..read more

Several years back, Hugh Rogers was in my office talking about his cannabis company. Way back then, the plan was to grow in Germany and be first on the continent, using an old wartime bunker as a ‘safe growing facility’. Those plans morphed quickly as the reality of the cannabis space became clear. The cannabis market did what it did, and weed wasn’t all it was cracked up to be… this is no secret. But while some ran their weed deals into walls and off cliffs like Wile E. Coyote, insisting any day now the good time would start to roll… Rogers tacked left. EVOLUTION BEATS REVOLUTION Rogers didn ..read more

There’s no better due diligence in the psychoactive drug space than Health Canada. Loads of pharma companies have investor decks that promise they’ll one day be in the psychedelics business, the MDMA business, even mescaline, but getting licensed to be involved in those spaces is not an easy thing. Lophos Pharmaceuticals Corp (MESC.C) recently received a major boost from Health Canada in the form of an expanded license for their operations involving controlled substances at their Napanee, Ontario facility. In simpler terms, the license expansion means they can now handle, store, sell, and tran ..read more

There’s no better due diligence in the psychoactive drug space than Health Canada. Loads of pharma companies have investor decks that promise they’ll one day be in the psychedelics business, the MDMA business, even mescaline, but getting licensed to be involved in those spaces is not an easy thing. Lophos Pharmaceuticals Corp (MESC.C) recently received a major boost from Health Canada in the form of an expanded license for their operations involving controlled substances at their Napanee, Ontario facility. In simpler terms, the license expansion means they can now handle, store, sell, and tran ..read more

If you go back on a long enough timeline, every company on the Canadian exchange has probably got three or four collapses and re-builds under their belt from the days back before they got where they’re currently going. Take any company currently exploring for silver and it was likely a cannabis company a few years back, then a biotech company before that, a fake meat company, a blockchain company, an e-sports company, a bike-share start-up, a VR programmer, and they’re thinking hard about maybe doing something in AI if the whole metals thing doesn’t work out. This isn’t a design flaw in the Ca ..read more